Interventional device developer Boston Scientific has launched its Expect endoscopic ultrasound aspiration needle.
Used to acquire tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal tract, Expect received U.S. Food and Drug Administration (FDA) clearance and the European CE Mark earlier this year, according to the vendor. Boston Scientific is marketing the needle in the U.S., Europe, and other international markets.
